Ioxilan is a diagnostic contrast agent used in various medical imaging procedures, such as angiography, urography, and computed tomographic scans. Intravascular injection results in opacification of vessels in the path of flow of the contrast medium, permitting radiographic visualization of the internal structures of the human body until significant hemodilution occurs.
- Mechanism
- Curator reviewed
Intravascular injection results in opacification of vessels in the path of flow of the contrast medium, permitting radiographic visualization of the internal structures of the human body until significant hemodilution occurs.
- Primary indication
- When administered intra-arterially, Ioxilan is indicated for the following diagnostic tests: cerebral arteriography (300 mgI/mL), coronary arteriography and left ventriculography (350 mgI/mL), visceral angiography(350 mgI/mL), aortography(350 mgI/mL), and peripheral arteriography(350 mgI/mL).Curator reviewed · 8 structured indications
- Formula / weight
- C18H24I3N3O8 · 791.116 g/mol (avg)
- First approval
- United States, 2002
- Code names
- CCRIS 6727 · CID3743 · LS-29720 · MOLI00098
Resolves to
UUMLTINZBQPNGF-UHFFFAOYSA-NSMILESCC(=O)N(CC(O)CO)C1=C(I)C(C(=O)NCC(O)CO)=C(I)C(C(=O)NCCO)=C1IWhat you can answer from here — as of March 06, 2025
Which other approved drugs treat the same conditions as Ioxilan, and which companies have late-stage candidates in those indications?
Create a free account or log in to explore the full data card.
Create Account